|Articles|September 1, 2009
- Applied Clinical Trials-09-01-2009
- Volume 0
- Issue 0
Applied Clinical Trials Digital Edition - September 2009
REGULATORY : Comprehensive Guide for Generic Drug Trials The Unique Concerns of Recombinant DNA Research TRIAL DESIGN : A Crash Course in Adaptive Also in this issue : Sponsors Challenged by Globalization, GCP Inspections Unite EMEA and FDA, Post Credit Crunch R&D Opportunities
Advertisement
Articles in this issue
about 17 years ago
The Spotlight Falls on Indiaabout 17 years ago
eClinical Software: September 2009about 17 years ago
Into the Aftermath of M&Aabout 17 years ago
EMEA and FDA Team Up on GCPabout 17 years ago
Does Size Matter in Partnershipsabout 17 years ago
An Assessment of Adaptiveabout 17 years ago
Business and People Update September 2009about 17 years ago
eCTD Training Effortsabout 17 years ago
Global Development Challenges Sponsorsabout 17 years ago
Regulating the Generic Drug ProcessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
2
Beyond Patient Centricity: What Rare Disease Research Gets Right
3
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
4
ACT Brief: Human Readiness as Operational Foundation, Early Phase Capacity Consolidation, and AI-Driven Patient Matching Scale
5